Enzymatica AB (publ) (STO:ENZY)

Enzymatica AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	53.9	45.58	50.9	48.95	57.24
Revenue Growth (YoY)	18.27%	-10.47%	4.00%	-14.49%	-48.54%
Cost of Revenue	20.78	14.86	19.04	20.49	23.89
Gross Profit	33.13	30.72	31.86	28.45	33.35
Selling, General & Admin	69.67	68.02	67.79	71.5	55.42
Research & Development	15.66	15.46	15.31	26.5	24.21
Other Operating Expenses	-0.84	-0.71	-3.17	-1.33	-1.04
Operating Expenses	84.49	82.77	79.93	96.67	78.6
Operating Income	-51.37	-52.05	-48.06	-68.22	-45.25
Interest Expense	-1.23	-1.72	-2.09	-1	-0.89
Interest & Investment Income	0.76	0.52	0.34	0.03	0
Currency Exchange Gain (Loss)	-	-0.08	0.09	0.43	0.43
Other Non Operating Income (Expenses)	0	-0	0	0	-
EBT Excluding Unusual Items	-51.84	-53.34	-49.72	-68.75	-45.7
Pretax Income	-51.84	-53.34	-49.72	-68.75	-45.7
Income Tax Expense	0.05	-0.16	0.01	-0.09	-0.31
Net Income	-51.89	-53.18	-49.73	-68.66	-45.39
Net Income to Common	-51.89	-53.18	-49.73	-68.66	-45.39
Shares Outstanding (Basic)	243	193	164	154	147
Shares Outstanding (Diluted)	243	193	164	154	147
Shares Change (YoY)	25.94%	17.34%	6.45%	5.24%	2.66%
EPS (Basic)	-0.21	-0.28	-0.30	-0.44	-0.31
EPS (Diluted)	-0.21	-0.28	-0.30	-0.44	-0.31
Free Cash Flow	-41.2	-60.9	-41.02	-68.28	-41.49
Free Cash Flow Per Share	-0.17	-0.32	-0.25	-0.44	-0.28
Gross Margin	61.45%	67.40%	62.59%	58.13%	58.26%
Operating Margin	-95.30%	-114.22%	-94.42%	-139.37%	-79.04%
Profit Margin	-96.27%	-116.68%	-97.69%	-140.26%	-79.30%
Free Cash Flow Margin	-76.44%	-133.63%	-80.58%	-139.50%	-72.49%
EBITDA	-48.54	-49.23	-44.96	-65.08	-43.11
EBITDA Margin	-90.05%	-108.01%	-88.32%	-132.95%	-75.30%
D&A For EBITDA	2.83	2.83	3.11	3.14	2.14
EBIT	-51.37	-52.05	-48.06	-68.22	-45.25
EBIT Margin	-95.30%	-114.22%	-94.42%	-139.37%	-79.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.